These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 31495204)
1. A Model of Blood Component-Heart Interaction in Cardiac Ischemia-Reperfusion Injury using a Langendorff-Based Ex Vivo Assay. Muessig JM; Kaya S; Moellhoff L; Noelle J; Hidalgo Pareja L; Masyuk M; Gerdes N; Pernow J; Kelm M; Jung C J Cardiovasc Pharmacol Ther; 2020 Mar; 25(2):164-173. PubMed ID: 31495204 [TBL] [Abstract][Full Text] [Related]
2. RevaTen platelet-rich plasma improves cardiac function after myocardial injury. Mishra A; Velotta J; Brinton TJ; Wang X; Chang S; Palmer O; Sheikh A; Chung J; Yang PC; Robbins R; Fischbein M Cardiovasc Revasc Med; 2011; 12(3):158-163. PubMed ID: 21122486 [TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors. Zhong B; Wang DH Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1681-90. PubMed ID: 19812353 [TBL] [Abstract][Full Text] [Related]
4. Cardiac vulnerability to ischemia/reperfusion injury drastically increases in late pregnancy. Li J; Umar S; Iorga A; Youn JY; Wang Y; Regitz-Zagrosek V; Cai H; Eghbali M Basic Res Cardiol; 2012 Jul; 107(4):271. PubMed ID: 22648276 [TBL] [Abstract][Full Text] [Related]
5. Poor glycemic control impairs the cardioprotective effects of red blood cells on myocardial ischemia/reperfusion injury. Muessig JM; Moellhoff L; Noelle J; Kaya S; Hidalgo Pareja L; Masyuk M; Roden M; Kelm M; Jung C Nitric Oxide; 2020 Apr; 97():1-10. PubMed ID: 31981741 [TBL] [Abstract][Full Text] [Related]
6. Characteristics of Dexmedetomidine Postconditioning in the Field of Myocardial Ischemia-Reperfusion Injury. Bunte S; Behmenburg F; Majewski N; Stroethoff M; Raupach A; Mathes A; Heinen A; Hollmann MW; Huhn R Anesth Analg; 2020 Jan; 130(1):90-98. PubMed ID: 31633505 [TBL] [Abstract][Full Text] [Related]
7. Effect of maturation on the resistance of rat hearts against ischemia. Study of potential molecular mechanisms. Griecsová L; Farkašová V; Gáblovský I; Khandelwal VK; Bernátová I; Tatarková Z; Kaplan P; Ravingerová T Physiol Res; 2015; 64(Suppl 5):S685-96. PubMed ID: 26674286 [TBL] [Abstract][Full Text] [Related]
10. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin. Bayrami G; Karimi P; Agha-Hosseini F; Feyzizadeh S; Badalzadeh R J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):174-183. PubMed ID: 28901167 [TBL] [Abstract][Full Text] [Related]
11. Remote ischemic preconditioning impairs ventricular function and increases infarct size after prolonged ischemia in the isolated neonatal rabbit heart. Schmidt MR; Støttrup NB; Michelsen MM; Contractor H; Sørensen KE; Kharbanda RK; Redington AN; Bøtker HE J Thorac Cardiovasc Surg; 2014 Mar; 147(3):1049-55. PubMed ID: 23871143 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the Langendorff Perfused Isolated Mouse Heart Model of Global Ischemia-Reperfusion Injury: Impact of Ischemia and Reperfusion Length on Infarct Size and LDH Release. Rossello X; Hall AR; Bell RM; Yellon DM J Cardiovasc Pharmacol Ther; 2016 May; 21(3):286-95. PubMed ID: 26353758 [TBL] [Abstract][Full Text] [Related]
13. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression. Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833 [TBL] [Abstract][Full Text] [Related]
14. Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro. Zhang R; Fang W; Han D; Sha L; Wei J; Liu L; Li Y Planta Med; 2013 Sep; 79(14):1289-97. PubMed ID: 23929248 [TBL] [Abstract][Full Text] [Related]
15. Effects on cardiac function, remodeling and inflammation following myocardial ischemia-reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice. Pluijmert NJ; Bart CI; Bax WH; Quax PHA; Atsma DE Sci Rep; 2020 Oct; 10(1):16601. PubMed ID: 33024178 [TBL] [Abstract][Full Text] [Related]
16. Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury. House SL; Castro AM; Lupu TS; Weinheimer C; Smith C; Kovacs A; Ornitz DM Am J Physiol Heart Circ Physiol; 2016 Mar; 310(5):H559-71. PubMed ID: 26747503 [TBL] [Abstract][Full Text] [Related]
17. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice. Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290 [TBL] [Abstract][Full Text] [Related]
18. [In vitro heart models simulating in vivo cardiac ischemia-reperfusion injury]. Jiao B; Zhang L; Yu LQ; Lu YM; Yue ZJ; Yu ZB Sheng Li Xue Bao; 2013 Dec; 65(6):647-53. PubMed ID: 24343723 [TBL] [Abstract][Full Text] [Related]
19. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury. Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692 [TBL] [Abstract][Full Text] [Related]
20. Hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity From the Red Blood Cell. Sun CW; Yang J; Kleschyov AL; Zhuge Z; Carlström M; Pernow J; Wajih N; Isbell TS; Oh JY; Cabrales P; Tsai AG; Townes T; Kim-Shapiro DB; Patel RP; Lundberg JO Circulation; 2019 Jun; 139(23):2654-2663. PubMed ID: 30905171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]